NDAORALTABLET
Approved
Feb 2012
Lifecycle
Peak
Competitive Pressure
0/100
Clinical Trials
2
Clinical Trials (2)
Balsalazide Disodium vs. Mesalamine in Mildly to Moderately Active Ulcerative Colitis
Started May 2006
400 enrolled
Inflammatory Bowel DiseaseUlcerative Colitis
New Tablet Formulation and Dosing Regimen of Balsalazide Disodium in Mildly to Moderately Active Ulcerative Colitis
Started Dec 2005
225 enrolled
Ulcerative Colitis
Loss of Exclusivity
LOE Date
Jun 23, 2031
64 months away
Patent Expiry
Jun 23, 2031